“Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA”, J of Skin, vol. 8, no. 6, p. s471, Nov. 2024, doi: 10.25251/skin.8.supp.471.